Navigation Links
Tongjitang Chinese Medicines Company Announces Resignation of CFO, Effective December 2, 2010
Date:9/8/2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... SAN DIEGO , June 19, 2013   Nektar ... top-line results from a human abuse liability (HAL) study for ... slow rate of entry into the brain.  This slow rate ... lead to the abuse of and addiction to current opioid ... NKTR-181 was rated similar to placebo in "drug ...
(Date:6/19/2013)... Israel , June 19, 2013 /PRNewswire/ ... from a phase I study in volunteers, and preliminary ... patients, of ND0612, were presented at the 2013 International ... a proprietary levodopa/carbidopa liquid drug formula under development for ... would maintain constant levodopa plasma concentrations. ND0612 ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6
... Diamyd Medical announces,today that the Swedish Medical Products ... in children with high risk to develop type 1,diabetes. ... ) , "To vaccinate children ... Medical,s long term goals," says Elisabeth Lindner, President and ...
... Criteria to Help Facilitate EHR Adoption in Small, ... The Certification Commission for Healthcare Information Technology ... certifying electronic health records (EHRs), has announced it ... The CCHIT,s decision was in part a response ...
Cached Medicine Technology:Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved 2Certification Commission for Healthcare Information Technology to Develop Dermatology-Specific Functionality Criteria for Electronic Health Record (EHR) Technology 2
(Date:6/20/2013)... Salt Lake City, UT (PRWEB) June 20, 2013 ... the #1 assurance solution that guides users through a ... interfaces. The new website launched today extends the ... broad audience of HIPAA Security Officers, HIPAA Privacy Officers, ... HIPAA compliance, security, privacy, consulting, measures, processes, policies and ...
(Date:6/19/2013)... 20, 2013 With the winter season ... together their winter season Santiago day trips ... trips in and around Santiago this season, expert mountain ... Central Andes for backcountry skiing, challenging rock climbing adventures, ... have always dreamed of skiing in Chile , ...
(Date:6/19/2013)... IL (PRWEB) June 19, 2013 Brand new Hypertrophy ... for the 4 day sale on the Hypertrophy Max program. ... next 24 hours so those that are interested must act quickly. ... all new Hypertrophy Max bonus is a free 12 month all ... Monte. , According to Ryan Davids "Live Large TV is a ...
(Date:6/19/2013)... Go Classy Tours has the reputation for ... over 25 Years. These resorts, draw many clients from ... bars and nude hot tubs. Grand Lido Negril was ... SuperClubs re-branded the resort to a Breezes and dis-continued the ... the Resort fell off dramatically. "Groups just went to ...
(Date:6/19/2013)... As warmer weather arrives and vacations begin, Asheville’s ... summertime packages. , “Whether guests are traveling to Asheville ... staycation, we think that these available packages will offer ... so beautiful in the summertime and there is a ... can choose from, based on their interests, offers something ...
Breaking Medicine News(10 mins):Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2
... goal to discover a drug that one day treats alcoholism, ... pinpointing the mechanisms in the brain that respond to alcohol. ... the UH College of Pharmacy, received a three-year, $450,000 grant ... the end, his team hopes their research will help lead ...
... suppresses the development of prostate tumors, promotes the growth of ... an article published online on September 20 in the ... Paul-Henri Romeo and colleagues find that TAL1, a protein ... acute lymphoblastic leukemia (T-ALL), drives expression of NKX3.1. Eliminating ...
... benefit from some of the tuberculosis vaccines currently in development, ... to activate a specific molecule that is an early participant ... a recent Ohio State University study suggests that in older ... of TB infection. The animal research suggests that the ...
... at the University of Utah determined that the 2009 ... neurological complications in children than the seasonal flu. ... Full details of the study, the most extensive ... are published in the September issue of Annals ...
... By Steven Reinberg HealthDay Reporter , ... called pazopanib could prove effective against difficult-to-treat cases of ... can be treated with surgery or radioiodine, but about ... form of the disease. Pazopanib (Votrient), already ...
... brain injury (TBI) is a serious public health problem in ... people sustain a traumatic brain injury annually. While the majority ... injuries contribute to a substantial number of deaths and cases ... available to treat TBI: a variety of single drugs have ...
Cached Medicine News:Health News:Drug to treat alcoholism goal of UH professor's research 2Health News:Elderly might not benefit from TB vaccines in development 2Health News:Elderly might not benefit from TB vaccines in development 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2Health News:New Drug Promising for Advanced Thyroid Cancer 2
... Sports Medicine™ POLYSORB™ Soft Tissue Anchor 3 mm ... soft tissue to bone using sutures. The resorbable ... in the bone, and is used to attach ... a resorbable copolymer, derived from glycolide and lactide ...
... USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 2 ... attach soft tissue to bone using sutures. The ... hole in the bone, and is used to ... made of a resorbable copolymer, derived from glycolide ...
Sutureless Harpoon Tip...
... type of anchor is generally utilized when a ... into the bone. Unlike other anchors that require ... does not have that limitation. The only instrument ... a mallet. The 4.4mm Stainless Steel Anchor is ...
Medicine Products: